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Synergic chemoprevention with dietary carbohydrate
restriction and supplementation of AMPK-activating
phytochemicals: the role of SIRT1
Jong Doo Leea,b,h,*, Min-Ah Choib,*, Simon Weonsang Roc,d,*, Woo Ick Yange,
Arthur E.H. Chob, Hye-Lim Jud,f, Sinhwa Baekd,f, Sook In Chungd,f,
Won Jun Kangb, Mijin Yunb and Jeon Han Parkg
Calorie restriction or a low-carbohydrate diet (LCD) can
increase life span in normal cells while inhibiting
carcinogenesis. Various phytochemicals also have calorie
restriction-mimetic anticancer properties. We investigated
whether an isocaloric carbohydrate-restriction diet and
AMP-activated protein kinase (AMPK)-activating
phytochemicals induce synergic tumor suppression. We
used a mixture of AMPK-activating phytochemical extracts
including curcumin, quercetin, catechins, and resveratrol.
Survival analysis was carried out in a B16F10 melanoma
model fed a control diet (62.14% kcal carbohydrate,
24.65% kcal protein and 13.2% kcal fat), a control diet with
multiple phytochemicals (MP), LCD (16.5, 55.2, and
28.3% kcal, respectively), LCD with multiple phytochemicals
(LCDmp), a moderate-carbohydrate diet (MCD, 31.9, 62.4,
and 5.7% kcal, respectively), or MCD with phytochemicals
(MCDmp). Compared with the control group, MP, LCD, or
MCD intervention did not produce survival benefit, but
LCDmp (22.80±1.58 vs. 28.00±1.64 days, P= 0.040) and
MCDmp (23.80±1.08 vs. 30.13±2.29 days, P= 0.008)
increased the median survival time significantly.
Suppression of the IGF-1R/PI3K/Akt/mTOR signaling,
activation of the AMPK/SIRT1/LKB1pathway, and NF-κB
suppression were the critical tumor-suppression
mechanisms. In addition, SIRT1 suppressed proliferation of
the B16F10 and A375SM cells under a low-glucose
condition. Alterations in histone methylation within Pten and
FoxO3a were observed after the MCDmp intervention. In the
transgenic liver cancer model developed by hydrodynamic
transfection of the HrasG12V and shp53, MCDmp and
LCDmp interventions induced significant cancer-prevention
effects. Microarray analysis showed that PPARα increased
with decreased IL-6 and NF-κB within the hepatocytes after
an MCDmp intervention. In conclusion, an isocaloric
carbohydrate-restriction diet and natural AMPK-activating
agents induce synergistic anticancer effects. SIRT1 acts as
a tumor suppressor under a low-glucose
condition. European Journal of Cancer Prevention 25:54–64
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Introduction
Calorie restriction (CR), defined as 20–40% restriction of
the daily energy intake, extends the longevity of normal
cells, but suppresses tumor growth (Colman et al., 2009).
Inhibition of the insulin-like growth factor-1 receptor
(IGF-1R)/phosphatidylinositol-3-kinase (PI3K)/Akt and
mitogen-activated protein kinase pathways have been
proposed as underlying tumor-suppression mechanisms
(Dunn et al., 1997; Mjiyad et al., 2011). In particular, acti-
vation of the AMP-activated protein kinase (AMPK)
pathway plays a crucial role through increased cellular
NAD+/NADH ratio, which in turn activates NAD+-
dependent class III histone deacetylase, silent mating-type
information regulation 2 homolog 1 (SIRT1), and liver
kinase B1 (LKB1). This signaling pathway results in a
closed-loop AMPK/SIRT1/LKB1 activation process with
tumor growth suppression (Lan et al., 2008; Shackelford
and Shaw, 2009; Ruderman et al., 2010).
However, CR has major limitations including weight loss,
especially in patients with cancer in the advanced stage.
Recently, an isocaloric carbohydrate-free ketogenic diet or
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a low-carbohydrate diet (LCD, carbohydrate intake < 20%
of the daily caloric intake) has been introduced as a sup-
portive dietary intervention (Last and Wilson, 2006; Masko
et al., 2010; Ho et al., 2011; Seyfried et al., 2012). These
interventions might also produce metabolic disturbances
such as ketoacidosis or even weight loss (Bravata et al.,
2003). Alternatively, a synthetic antidiabetic AMPK ago-
nist, metformin, has been proposed as a CR-mimetic
anticancer agent (Bost et al., 2012).
Various plant-derived bioactive phytochemicals includ-
ing curcumin, quercetin, (-)-epigallocatechin-3-gallate
(EGCG) in green tea extract, and resveratrol are known
to be CR-mimetic AMPK activators (Dasgupta and
Milbrandt, 2007; Pan et al., 2008; Park et al., 2009; Jung
et al., 2010) and SIRT1 activators as well (Chung et al.,
2010). Nevertheless, the anticancer effects of a single
phytochemical are minimal because of its poor bioavail-
ability, poor intestinal absorption, and rapid metabolism
despite strong anticancer activities in-vitro studies. A
single agent is only effective at an extremely high-dose
oral administration (Scott et al., 2009). In contrast, a
mixture of bioactive compounds exerts biological effects
at a much lower dose, with synergistic enhancement of
each individual compound (Liu, 2004; Ghosh et al., 2009;
Ricciardiello et al., 2011).
Previous studies have reported that metformin induced
massive apoptosis of cancer cells with glucose restriction,
whereas these anticancer effects were attenuated under a
high-glucose condition. Synergic tumor growth suppres-
sion has also been observed in mice when metformin was
used in combination with a glucose uptake inhibitor
(Cheong et al., 2011; Menendez et al., 2012). These data
suggest that energy restriction in combination with
AMPK-activating agents could enhance tumor suppres-
sion synergistically.
In this study, we tested whether an isocaloric
carbohydrate-restriction diet supplemented with natural
AMPK-activating agents would extend the survival time
in an animal model using C57BL6 mice bearing B16F10
melanoma. We also explored whether CR-induced
SIRT1 activation is oncogenic or acts as a tumor sup-
pressor as the role of SIRT1 in malignant tumors is still
controversial (Liu et al., 2009; Herranz and Serrano, 2010;
Roth and Chen, 2013). In addition, we evaluated the
chemoprevention effects of our dietary modification in a
transgenic liver cancer model.
Materials and methods
Dietary formulas
The Picolab Rodent Diet 5053 formula (LabDiet,
Brentwood, Missouri, USA) consisting of 62.14% kcal
carbohydrate, 24.65% kcal protein, and 13.2% kcal fat
with 3.07 kcal/g of metabolizable fuel value was used as
the control formula. We purchased the TestDiet 9G1X
formula (TestDiet, Brentwood, Missouri, USA) consisting
of 16.5% kcal carbohydrate, 55.2% kcal protein, and
28.3% fat with a 4.13 kcal/g fuel value for the LCD
intervention. We used green tea, curcumin, quercetin,
and resveratrol extracts for CR-mimetic AMPK-activating
agents. Approximately 5 mg of each phytochemical
extract/g was added to the control and to the LCD for-
mula to prepare the multiple phytochemical (MP) and
LCDmp formulas, respectively. We designed a moderate-
carbohydrate diet (MCD, < 50% of the daily carbohydrate
intake) formula consisting of 31.9% kcal carbohydrate,
62.4% kcal protein, and 5.7% kcal fat with 3.22 kcal/g of
fuel value, and prepared an MCDmp formula by adding
phytochemical extracts.
Survival analyses in the malignant melanoma model
B16F10 melanoma cells (1× 106 cells) were injected
subcutaneously into the back of 6-week-old C57BL6
male mice (Orient Bio Inc., Seongnam, Korea) after
preliminary feeding of each dietary formula ad libitum for
1 week. We divided the mice randomly into six groups:
control, MP, LCD, LCDmp, MCD, or MCDmp formula
(n= 15/group).
We carried out survival analysis using the Kaplan–Meier
method, and diet-induced tumor suppression mechan-
isms were investigated using tumor tissues removed from
the control (n= 6) and MCDmp (n= 5) groups.
Evaluation of energy-dependent signaling pathways
Western-blot analyses were carried out using antibodies
against proteins involved in energy-dependent signaling
pathways.
Evaluation of the role of SIRT1 under a carbohydrate
restriction condition
B16F10 mouse or human A375SM melanoma cells were
treated with various concentrations of SIRT1 Activator 3
(SA3), which is an allosteric SIRT1 activator (Nayagam
et al., 2006), under standard glucose (11 mmol/l) or low-
glucose (5.5 mmol/l) conditions in RPMI-1640 medium.
A viability assay was performed and we evaluated the
protein expression of p-AMPK, SIRT1, acetyl-p53 (Lys
382), acetyl-NF-κB, and nuclear fraction of the NF-κB
p65 subunit in the B16F10 melanoma cells cultured in a
standard medium or a low-glucose medium (LGM).
ChIP-on-chip microarray
Chromatin immunoprecipitation (ChIP) assay was per-
formed with the EpiQuik TM ChIP Kit (Epigentek,
Brooklyn, New York, USA) using randomly selected
melanoma tissue samples (n= 3/group from the control
and MCDmp groups). Chromatin preparation was per-
formed using an anti-H3K4me3 antibody as H3 methy-
lation precedes acetylation (Wang et al., 2001). An Agilent
microarray chip containing 97 651 oligonucleotide probes
(Agilent Technology, Palo Alto, California, USA) was
used for ChIP-on-chip analysis.
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cDNA microarray
Total RNA fraction was extracted from the melanoma
tissues removed from the control (n= 7) and MCDmp
groups (n= 6), and cDNA microarray was performed.
Confocal microscopy
Frozen tissue sections from the control and MCDmp
groups were prepared using a cryostat (micron HM-525;
Thermo Scientific Inc., Pittsburgh, Pennsylvania, USA)
at a 6-µm thickness. Immunohistochemistry to evaluate
cellular polarity and tyrosinase-related protein-1
(TYRP1) was performed.
Cancer-prevention effects in a transgenic liver cancer
model
We evaluated the cancer-prevention effects of each
dietary intervention in a transgenic liver cancer model
produced by transfection of the HrasG12V and shp53 into
C57BL6 male mice as described previously (Ju et al.,
2013).
This study was carried out in accordance with the Guide
for the Care and Use of Laboratory Animals of the
National Institutes of Health. The protocols of animal
experiments were approved by our Institutional Animal
Care and Use Committee (IACUC) (Number: 09-199-1
and 2012-0116).
Statistical analysis
Kaplan–Meier survival data were evaluated using the log-
rank (Mantel–Cox) test, and a P value less than 0.05 was
considered to be statistically significant. The statistical
analysis of gene expression on cDNA microarray was
carried out at the threshold of P less than 0.05 with more
than two fold-change of gene expression. The protein or
mRNA expression levels were evaluated as the percen-
tage of control signals (% control).
Detailed materials and methods are described in
Supplemental digital content 1.
Results
Survival analyses in the B16F10 melanoma model
Supplementation of a mixture of natural AMPK activators
under a normal control diet (MP intervention) did not
increase the survival time (Fig. 1a), although the mean
tumor volume was slightly smaller than that of the control
group (Supplemental digital content 2). Smaller tumor
volume with a slower tumor growth rate was also observed
in both LCD and LCDmp groups (Supplemental digital
content 3, P< 0.05). The median survival time was sig-
nificantly increased in the LCDmp (Fig. 1b) and the
MCDmp groups (Fig. 1c, Supplemental digital content 4)
compared with the control group. The MCD intervention
did not produce significant survival benefit (Fig. 1c).
18F-FDG MicroPET imaging showed a smaller tumor size
with lower intratumoral 18F-FDG uptake in the MCDmp
group compared with the control group (Fig. 2a). Protein
expression of the hexokinase type 2 (HK2) and pyruvate
kinase type M2 (PKM2) within tumor tissues was
decreased in the MCDmp group (Fig. 2b).
Alterations in energy-dependent signaling pathways
Serum glucose level was significantly lower in the
MCDmp group (106.1 ± 12.19 mg/dl) than in the control
group (148 ± 13.36 mg/dl) (P< 0.04), as also the serum
insulin level (0.10 ± 0.02 and 0.18 ± 0.02 ng/ml, respec-
tively, P< 0.02). Protein levels of the IGF-1R, PI3K, and
p-Akt at Thr308, phospho-ribosomal protein S6 kinase
(p-S6K) at Ser411, and the phospho-eukaryotic initiation
factor 4E-binding protein 1 (p-4E-BP1) at Thr37/46 were
decreased after the MCDmp intervention (Supplemental
digital content 5).
In theMCDmp group, theNAD+/NADH ratio was increased
(>3-fold difference) (Fig. 2c). The phosphorylated-liver kinase
B1 at Ser428 (p-LKB1-Ser428), phosphorylated-AMPK at
Thr172 (p-AMPK-Thr172), and SIRT1 were increased
independent of nicotinamide phosphoribosyltransferase
(NAMPT) expression. NF-κB in the nuclear fraction was
decreased (Fig. 2d). On confocal microscopy of melanoma
tissues removed from mice, peripheral tumor cells showed
restoration of cell polarity (Supplemental digital content 6).
Effects of SIRT1 on tumor cell proliferation
In-vitro MTT analyses showed that SA3 treatment did not
affect cellular proliferation of both B16F10 and human
melanoma cells in a standard glucose medium, but decreased
proliferation under a low-glucose condition along with
increasing p-AMPK in a dose-dependent manner (Fig. 3a,
Supplemental digital contents 7 and 8). The level of acetyl-
p53 was not decreased in the LGM despite increased SIRT1
expression (Fig. 3b). The NF-κB p65 subunit level in the
nucleus fraction was decreased in the LGM and further
suppressed after SA3 treatment (Fig. 3b and c).
Histone modification
The ChIP-on-chip study showed alterations in histone
methylation (H3K4me3) in the MCDmp group. In par-
ticular, H3K4me3 was increased within the promoter
region of the Pten and FoxO3a. ChIP-PCR analysis con-
firmed increased H3K4me3 within the Pten and FoxO3a
promoter regions (Fig. 4a) and increased expression of
these proteins as well as downstream Bim and BAX
(Fig. 4b). PTEN, FOXO3a, and Bim were also increased
in B16F10 melanoma cells cultured in a LGM (Fig. 4c).
cDNA microarray results
Forty-three genes were downregulated and two genes
were upregulated at the threshold of false discovery rate
corrected (P< 0.05) (Fig. 5a) in melanoma tumor tissues.
In particular, Mitf and Tyrp1 were decreased, along with
decreased vascular endothelial growth factor (VEGF) and
DEK oncoprotein mRNAs. In contrast, expression of the
serine peptidase inhibitor F member 1 (Serpinf1), which
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is known as the pigment epithelium derived factor was
increased (Supplemental digital content 9). Western-blot
analysis confirmed their protein expression patterns
(Fig. 5b). Confocal microscopy of tumor tissue samples
showed lower TYRP1 expression within the cytoplasm of
tumor cells with less pigmentation in the MCDmp group
(Fig. 5c and d). Compared with the MCD intervention,
MCDmp produced stronger anticancer effects including
suppression of the MITF, mTOR signaling, and mitogen-
activated protein kinase pathways (Fig. 5e).
Cancer-prevention effects in a transgenic liver cancer
model
Numerous tumor nodules developed throughout the
entire liver at 4 weeks after transfection of both HrasG12V
and shp53 DNAs. The nodules were proven to be poorly
differentiated aggressive tumors on H&E staining. Fewer
tumor nodules were observed only in the MCDmp and
LCDmp groups compared with the control group
(Supplemental digital content 10). There was no sig-
nificant difference in cancer-prevention effects in the
group in which MCDmp was started on the day of DNA
transfection (Group 2) however, fewer and smaller tumor
nodules developed when the MCDmp intervention was
started 2 weeks before DNA transfection (Group 3)
(Fig. 6a). Finally, postmortem liver tissues showed fewer
tumor nodules in Group 3 (Fig. 6b and c). On
Kaplan–Meier survival analysis, the overall survival was
significantly prolonged only in Group 3 (P< 3.5× 10−7,
Fig. 6d).
cDNA microarray analysis of the tumor-free liver tissues
showed upregulation of the peroxisome proliferator-
activated receptor α (PPARα) and downregulation of
numerous genes that regulated energy metabolism,
tumor initiation, and proliferation in Group 3 (Fig. 7a,
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Dietary effects on survival. (a) Kaplan–Meier survival analysis showed that AMPK-activating phytochemicals alone do not produce survival benefit in a
melanoma model. The median survival time was not significantly increased after the multiple phytochemical (MP) intervention. (b) Survival benefit was
not observed after the low-carbohydrate diet (LCD) intervention either. However, LCD supplemented with a mixture of phytochemicals (LCDmp)
significantly increased the median survival time. The median survival time of the control, LCD, and LCDmp groups was 22.80 ±1.58, 24.69 ±1.42, and
28.00±1.64 days after inoculation of melanoma cells, respectively. (c) The median survival time of the MCDmp group was also significantly increased
compared with that of the MCD and control groups (30.13 ±2.29, 25.40 ±1.24, and 23.80 ±1.08 days, respectively). (d) Tumor size of the MCDmp
group was smaller than that of the control group (arrow).
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Supplemental digital content 11). Among these, we
confirmed decreased mRNA expression of the IL-6 and
NF-κB in Group 3 compared with Group 1 using quan-
titative real-time PCR (Fig. 7b). H&E and TRITC–
phalloidin immunostaining of the tumor-free liver tissues
obtained 4 weeks after DNA transfection showed distorted
lobular arrangement and bile canaliculi in Group 1,
whereas normal liver architecture was grossly preserved in
Group 3 (Fig. 7c). SIRT1 expression was increased in Group
3 compared with Group 1 (Supplemental digital content 12).
Discussion
Glucose is a major energy source in both normal and cancer
cells. The glycolytic rate is increased in malignant tumors,
and the normal metabolic control mechanisms are modified
by numerous oncogenes to enhance the glycolytic rate
(Levine and Puzio-Kuter, 2010). Our study confirmed that
the inhibition of diet-induced hyperinsulinemia and the
IGF-1R/PI3K/Akt pathway along with downregulation of
the mTOR signaling could be important tumor-suppression
mechanisms of the MCDmp intervention. HK2 and PKM2,
which are the key enzymes that increase aerobic glycolysis
in cancer cells (Sebastian and Kenkare, 1997; Sun et al.,
2011), were also suppressed after the MCDmp intervention.
This resulted in reduced glucose uptake with a lower
intracellular glucose concentration (Fig. 2a and b), and this
process could generate a vicious cycle in tumor cell-
proliferation processes. Although amino acids, especially
glutamine, can potentiate cellular proliferation, glucose
restriction might inhibit glutamine uptake and cellular pro-
liferation despite abundant amino acids (Lopez-
Lazaro, 2008; Wellen et al., 2010).
AMPK/SIRT1/LKB1 closed-loop activation after energy
restriction plays an important role in tumor suppression.
SIRT1 activation might enhance tumor cell proliferation
Fig. 2
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In addition, the MCDmp intervention suppressed NF-κB p65 expression in the nuclear fraction of cells along with increased cytosolic IkB.
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through deacetylation of p53; however, AMPK counteracts
the deacetylase activity of SIRT1 on p53, but enhances p53
stability (Lee et al., 2012). Our study also showed that the
level of acetyl-p53 in B16F10 melanoma cells did not
decrease in a LGM even with increased SIRT1 expression.
In-vitro study showed that melanoma cell proliferation was
suppressed after treatment with an allosteric SIRT1 acti-
vator, SA3, along with AMPK activation in a dose-
dependent manner when tumor cells were cultured in a
LGM. Melanoma tissues from the MCDmp group showed
activation of the AMPK/SIRT1/LKB1 signaling with
apparent tumor growth suppression with restored cell
polarity compared with the control group. As cell polarity is
abolished during the carcinogenesis process (Lee and
Vasioukhin, 2008; Luo et al., 2010), our data clearly show
that our dietary modification inhibited tumor growth effec-
tively through the activation of AMPK/SIRT1/LKB1 sig-
naling, in particular, SIRT1 activation.
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NF-κB is an important downstream target of SIRT1 that
deacetylates the RelA/p65 subunit of NF-κB, thereby
decreasing NF-κB-induced transcription of the genes
encoding antiapoptotic proteins after SIRT1 activation
(Yeung et al., 2004). Our study showed decreased NF-κB
expression in tumor tissues removed from the MCDmp
group as well as in B16F10 melanoma cells cultured in a
LGM, especially after the treatment with SA3. Taken
together, our data clearly show that energy restriction-
induced SIRT1 activation is linked to tumor suppression.
FOXO3a is another target of SIRT1. Transcriptional
activity of the FOXO3a can be activated within the
nucleus by SIRT1-induced deacetylation of its lysine
residues or AMPK-induced phosphorylation (Greer et al.,
2007; Canto et al., 2009). Nutrient restriction could fur-
ther enhance FOXO3a activity through enhanced trans-
location of the FOXO3a into the nucleus following
inhibition of the PI3K/Akt signaling cascade (Calnan and
Brunet, 2008). Nuclear FOXO3a can act as a tumor
suppressor after binding to the promoters of various
genes including Bim (Czabotar et al., 2009) or removing
p53 from the SIRT1-binding sites (Nemoto et al., 2004).
In fact, our study showed increased nuclear FOXO3a
levels in both melanoma tissues from the MCDmp group
and B16F10 melanoma cells cultured in a LGM.
Epigenetic modification of tumor-related genes could be
involved in diet-induced tumor suppression. Li et al. (2010)
have already reported increased longevity in normal cells
after glucose restriction, but it resulted in growth inhibition
of cancer cells by epigenetic modification. In this study,
histone modification of the Pten and FoxO3a was observed
in the MCDmp group. Although carbohydrate restriction
alone can increase PTEN and FOXO3a expression, natural
AMPK-activating phytochemicals could synergistically
enhance tumor-suppression activities through various
anticancer activities including histone modification,
Fig. 4
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suppression of the energy-dependent signaling cascade,
and cancer-related inflammation (Surh, 2003; Link et al.,
2010).
cDNA microarray data showed final signaling pathways
that are specific for melanoma growth suppression. In
particular, MITF, which is the master transcription factor
regulating melanocyte differentiation, cell cycle pro-
gression, and survival, was suppressed with decreased
Tyrp1, which encodes tyrosinase interacting protein
within melanoma tissue after the MCDmp intervention
(Levy et al., 2006). Increased expression of pigment
epithelium derived factor, which is an endogenous
VEGF inhibitor, along with decreased VEGF, and DEK
oncoprotein suppression could play critical roles in
melanoma growth suppression by inhibiting angiogenesis
and antiapoptotic activities, respectively (Khodadoust
et al., 2009; Konson et al., 2010). Notably, the MCDmp
intervention produced stronger anticancer effects than
the MCD intervention. Therefore, the AMPK activation
induced from energy restriction and natural AMPK-
activating agents synergistically inhibit tumor growth,
although carbohydrate restriction or phytochemical sup-
plementation alone may not be effective in increasing the
survival time.
Dietary modification not only suppresses tumor cell
proliferation but also inhibits the development of cancer.
Fig. 5
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Diet-induced melanoma growth-suppression mechanism. (a) cDNA microarray analysis using melanoma tissues removed from the control and the
MCDmp groups showed significant alterations in gene expression. Red represents upregulated mRNAs and green represents downregulated
mRNAs. (b) The melanoma-specific proliferation markers, MITF and TYRP1, were decreased in the MCDmp group along with inhibition of VEGF,
activation of the endogenous angiogenesis inhibitor (PEDF), and downregulation of the DEK oncogene. (c) Confocal analysis confirmed significantly
decreased TYRP1 expression in the MCDmp group (green; anti-TYRP1, blue; DAPI). Inset images represent gross cut-sections of paraffin-embedded
tumor tissue blocks showing decreased pigmentation in the MCDmp group. (d) Compared with MCD intervention, the MCDmp group showed higher
expression of p-AMPK with suppression of the 4-EBP1, S6K1, ERK1/2, and MITF.
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In our transgenic hepatic tumor model, fewer tumor nodules
developed after LCDmp and MCDmp interventions. Our
data suggest that carbohydrate restriction with AMPK-
activating phytochemicals controls malignant transforma-
tion of cells synergistically despite cells already acquired
oncogenic properties through the suppression of the cancer-
related inflammatory process including inhibition of the NF-
κB/IL-6/STAT3 pathway (Yang et al., 2010). Increased
PPARα expression could also enhance chemoprevention
effects as CR or CR-mimetic phytochemicals might induce
PPARα expression directly or indirectly by AMPK activation
and inhibits various transcription factors, particularly NF-κB
(Seymour et al., 2010; Peters et al., 2012). Increased SIRT1
activity could negatively regulate NF-κB-dependent
STAT3 expression (Bernier et al., 2011). However, carbo-
hydrate restriction or supplementation of AMPK-activating
agents alone did not produce significant cancer-prevention
effects. Notably, cancer-prevention effects were not appar-
ent when dietary intervention was started after DNA
transfection. This suggests that a diet-induced metabolic
reprogramming period is necessary before malignant trans-
formation of cells for cancer prevention. Indeed, previous
data showed that the incidence of cancer was significantly
low in rhesus monkeys when CR was started at a young age
(Mattison et al., 2012).
In conclusion, we confirmed that isocaloric carbohydrate
restriction in combination with a mixture of natural AMPK-
activating agents could be an effective anticancer approach
through synergic activities of each dietary intervention in
animal models. SIRT1 enhances tumor suppression under
an energy restriction condition.
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Dietary effects on cancer prevention. (a) Numerous tumor nodules developed within the liver after transfection of the HrasG12V and shP53 genes
(Group 1). MCDmp intervention started after DNA transfection did not produce significant tumor-suppression activity (Group 2). However, fewer tumor
nodules (arrow) developed when MCDmp was started 2 weeks before DNA transfection (Group 3). Post-mortem liver tissues also showed numerous
tumor nodules throughout the liver in Group 1 (b)b, but fewer tumor nodules in Group 3 (c). (d) Kaplan–Meier survival analysis showed significant
survival benefit only in Group 3. The median survival time of Group 1, Group 2, and Group 3 was 36±0.77, 36±0.45, and 45±1.20 days, respectively.
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Group 3. Scale bar=5 μm.
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